License and Development Agreements (Details) - USD ($) $ in Thousands	1 Months Ended			12 Months Ended
	Oct. 31, 2023	Jan. 31, 2023	Sep. 30, 2022	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue				$ 4,055	$ 6,036
Expense incurred				32,126	39,573
NIAID Project NextGen clinical trial initiative	$ 5,000,000
Initial license issuance fee			$ 1,000
Payment annual development and commercial milestones		$ 37,000
Cancellation period, notice		90 days
Collaborative Arrangements
Disaggregation of Revenue [Line Items]
Total revenue				4,055	6,036
Expense incurred				1,900	5,300
Contract liability				8,368	$ 10,525
Exclusive License Agreement with SERI
Disaggregation of Revenue [Line Items]
Annual maintenance payments				75
Milestone payments				750
Exclusive License Agreement with the CU
Disaggregation of Revenue [Line Items]
Annual maintenance payments				$ 20